-

Trinity Life Sciences Names First Chief Technology Officer

Rajeev Rangachari Plans to Bolster a Culture of Innovation

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, today announced the appointment of Rajeev Rangachari to serve as the Company’s first-ever Chief Technology Officer (CTO). Mr. Rangachari brings significant experience in building flexible, scalable solutions for life sciences organizations to Trinity.

As CTO, Mr. Rangachari will infuse technology into every aspect of Trinity’s offerings and workflow, accelerating business processes with technology assets. He will lead a global team of technologists and life sciences domain experts as they focus on the new opportunities in Artificial Intelligence (AI), drive innovation in spaces that aren’t traditionally tech-enabled and ensure adoption of best practices in security and compliance.

“Generative AI and, more broadly, AIML in all its forms will be transformative for life sciences in the next few years. As we tackle these technological disruptions on behalf of our clients, having a seasoned technology leader in the new CTO role is vital,” explained Leslie Orne, President & CEO of Trinity Life Sciences. “I am delighted Rajeev is on the team and bringing his high-energy, outcomes-focused leadership style and unique skillset to bear on these crucial initiatives.”

“From a global life sciences technology perspective, the power of Generative AI provides an opportunity to bring people without technical backgrounds into the leading edge of data science,” added Rajeev Rangachari, CTO of Trinity Life Sciences. “I am honored to lead Trinity’s technology strategy at such an exciting moment and look forward to bolstering an already innovative culture by enhancing and developing world-class tools and technology that support life sciences commercialization.”

Prior to accepting the CTO role, Mr. Rangachari most recently served as D Cube Analytics’ Chief Technology Officer. D Cube Analytics was acquired by Trinity Life Sciences in July 2022.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With more than 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Life Sciences Unveils Breakthrough AI Model That Detects Type 1 Diabetes a Year Before Symptoms Appear

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in advisory, insights and analytics for the life sciences industry, presented results from a new study demonstrating the potential of an artificial intelligence and machine learning (AIML) model to detect type 1 diabetes (T1D) at least one year before a patient’s clinical diagnosis. Leveraging Trinity’s leading-edge AI capabilities and deep therapeutic expertise, with support from Sanofi, the model also maintains improved accuracy...

Trinity Life Sciences Unveils Critical Insights for Navigating the Path From Initial Generative AI Adoption to Full-Scale Transformation

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in advisory, insights and analytics for the life sciences industries, discusses the journey to achieving successful transformation with generative AI (GenAI) in a new white paper, entitled Technology with a Point of View: Encoding Life Sciences Expertise with AI. GenAI is a technological disruption with significant potential to revolutionize biopharmaceutical commercialization across functions and use cases by: Changing how life...

Trinity Life Sciences Expands Data Partnership Network to Revolutionize Commercialization in Community Oncology

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in advisory, insights and analytics for the life sciences industries, announces a strategic collaboration with Ontada, a McKesson business and leader in community oncology real-world data, clinical education and point-of-care technologies. This relationship will provide life sciences companies with real-time, actionable intelligence and critical insights to drive strategic decisions both pre- and post-product launch. Together, the...
Back to Newsroom